Find Academic Supervisors

Abi SanthakumarView profile

Associate Professor

• Haematology
• Cardiovascular Diseases
• Nutraceuticals
• +10 more

Abi Santhakumar is an Associate Professor of Haematology and serves as Associate Head of School for Research & Graduate Studies and for Medical Science & Pathology at Charles Sturt University. Their research focuses on the role of dietary bioactive compounds, particularly polyphenols and antioxidants, in modulating risk factors for cardiovascular disease, diabetes, and obesity, with a special emphasis on haemostasis and platelet activity under oxidative stress. They also investigate pre-analytical errors in pathology laboratories to improve diagnostic quality. PhD in Haematology, Griffith University (2014) Their research interests lie at the intersection of nutrition, medical science, and clinical pathology, especially exploring how dietary antioxidants can prevent thrombosis. Key areas include polyphenol characterization, oxidative stress modulation, and improving laboratory diagnostics. Their work contributes to UN Sustainable Development Goals in health and education. The recent publications show a strong trend in clinical haematology, diagnostic improvement, and nutritional interventions, with increasing focus on pre-analytical processes and thrombin generation assays. There is a clear interdisciplinary approach combining food science, pathology, and public health. Excellence Awards - Successful Graduates (2019) Executive Deans Teaching Award (2023) Graham Centre Cat 1 teaching support (2019) Graham Centre Conference support scheme (2019) Continuing professional development in higher education (2021, Grant) Abi Santhakumar is a registered supervisor and has mentored students in haematology, nutrition, and medical science. They have secured competitive grants and are actively involved in academic leadership and curriculum development. Their collaborative work includes partnerships with national and international institutions in haemostasis research and laboratory medicine. They are actively engaged in professional networks, particularly through the Australian Institute of Medical and Clinical Scientists (AIMS), where they serve as Director and organize seminar series on haemostasis and laboratory harmonization, contributing to national standards in medical science.

Roger SturmeyView profile

Senior Lecturer

• Reproductive Physiology
• Metabolic Regulation
• Embryology
• +7 more

Roger Sturmey is a Senior Lecturer in Reproductive Medicine at Hull York Medical School. His career spans reproductive physiology, embryology, and metabolic research, with a focus on understanding how metabolic activity programs cellular behavior in early development. PhD from the University of York (UK), investigating porcine embryo metabolism Postdoctoral work on DNA damage in oesophageal cancer Research interests include: Metabolic regulation of fertility Long-term metabolic health of offspring Platelet function in development Interplay between DNA damage and metabolism in preimplantation embryos Impact of maternal diet on oocyte/embryo quality Key methodologies employed by his lab include nanofluorometric assays, nanorespirometry, Seahorse bioenergetics, and advanced imaging techniques. Scientific awards : Wellcome Trust VIP Fellowship Medical Research Council Funding

Bonnie L. PadwaView profile

Professor

• Craniofacial Anomalies
• Orthognathic Surgery
• Cleft Lip and Palate
• +7 more

Dr. Bonnie L. Padwa is a distinguished Professor in the Department of Oral and Maxillofacial Surgery at Harvard Medical School and a clinician-scientist at Boston Children's Hospital. With dual MD and DMD degrees from Harvard, she has established herself as a leading expert in craniofacial anomalies, particularly focusing on cleft lip/palate and hemifacial microsomia. Her clinical practice is complemented by extensive translational research that bridges bench science with patient care. Dr. Padwa's educational background includes: Doctor of Medicine in Dentistry (DMD) from Harvard School of Dental Medicine (1988) MD from Harvard Medical School (1990) General Surgery Residency at Massachusetts General Hospital (1992) Oral & Maxillofacial Surgery Residency at Massachusetts General Hospital/Brigham and Women's/Boston Children's Hospital (1994) Craniofacial Fellowship at Brigham & Women's Hospital/Boston Children's Hospital (1993) Her research interests span multiple dimensions of craniofacial care. Clinically, she focuses on optimizing treatment outcomes for children with craniofacial anomalies, including rare disorders like facial infiltrating lipomatosis and more common conditions such as cleft lip/palate. Her translational work investigates bone cell function, particularly examining how intra-operative graft handling affects human bone cells and characterizing RANKL-mediated responses to autologous growth factors in platelet-rich plasma. Additionally, she has pioneered research in activity-based costing analyses to optimize healthcare quality while minimizing costs for patients and families. Analysis of Dr. Padwa's extensive publication record (including over 100 articles with numerous 2024-2025 publications) reveals a strong emphasis on evidence-based approaches to craniofacial surgery. Her work consistently addresses critical questions in surgical outcomes, with particular focus on alveolar bone grafting success rates, surgical techniques for cleft repair, and optimizing postoperative recovery protocols. Recent publications demonstrate increasing attention to healthcare economics and value-based care within craniofacial surgery.

• Hematology
• Genomics
• Thrombosis Research
• +3 more

Dr. Justine Ryu is an Assistant Professor of Medicine (Hematology) at Yale School of Medicine . She specializes in treating blood disorders such as sickle cell anemia, thrombosis, anemia, bleeding disorders, and platelet disorders. Her research focuses on whole-genome sequencing in the All of Us Research Program , particularly exploring genetic variants associated with thrombosis and coagulation disorders. She completed her MD at Boston University School of Medicine, residency at Boston Medical Center, and fellowship at Beth Israel Deaconess Medical Center, where she also earned a T32 Postdoctoral Fellowship in Hemostasis and Thrombosis. Her recent work includes studies on protein S abnormalities , cancer-associated thrombosis , and genetic modifiers of thrombosis risk. She has published in journals like Blood Advances and Cell Reports . Education: MD: Boston University School of Medicine (2019) Residency: Beth Israel Deaconess Medical Center (2019) Fellowship: Beth Israel Deaconess Medical Center (2023) Dr. Ryu’s clinical practice focuses on Smilow Classical Hematology at Yale, treating patients in Orange, CT. She actively collaborates on projects integrating multiomic datasets and AI-driven risk assessment for hematologic diseases.

• Lipoprotein metabolism
• HDL receptors
• Atherosclerosis
• +5 more

Bernardo Trigatti is a Professor in the Department of Biochemistry & Biomedical Sciences at McMaster University's Faculty of Health Sciences. His research has established him as a leading expert in lipoprotein metabolism and cardiovascular disease mechanisms, with a specific focus on the Scavenger Receptor Class B Type I (SR-BI) and its role in HDL metabolism, cholesterol transport, and atherosclerosis development. Dr. Trigatti's research spans over three decades, beginning with early work on fatty acid uptake mechanisms in the 1990s and evolving into sophisticated studies of SR-BI function in cardiovascular disease. His laboratory has made seminal contributions to understanding how SR-BI regulates HDL metabolism, macrophage function in atherosclerotic plaques, and protection against cardiotoxicity. His work frequently employs genetically modified mouse models, particularly SR-BI knockout mice, which have become standard tools in cardiovascular research. Recent publications demonstrate continued innovation in the field, with studies examining novel therapeutic approaches for atherosclerosis and exploring the intersection between lipid metabolism and inflammatory pathways. The trajectory of Dr. Trigatti's scholarly work reveals an increasingly sophisticated understanding of the molecular mechanisms connecting HDL metabolism with cardiovascular disease. His early research established fundamental mechanisms of lipid transport, while more recent work has expanded into therapeutic applications, examining how modulation of SR-BI signaling could protect against atherosclerosis, myocardial infarction, and drug-induced cardiotoxicity. His 2021-2025 publications show particular interest in the relationship between HDL function and inflammatory processes, with studies examining how HDL signaling affects macrophage survival in atherosclerotic plaques and how SR-BI interactions with other receptors (like S1PR1) mediate protective effects. Dr. Trigatti has taught courses including Drug Discovery and Development (BIOMEDDC 3B06A/B) and Inquiry II: Biochemistry (HTHSCI 2E03), demonstrating his commitment to training the next generation of biomedical scientists. His scholarly impact is evident in the widespread citation of his work across multiple disciplines and its recognition by news outlets and scientific platforms.

Anthony CarrView profile

Professor

• Electrocardiography
• Blood pressure monitoring
• Platelet function

Anthony Carr serves as a Professor in the Department of Small Animal Clinical Sciences at the Western College of Veterinary Medicine, University of Saskatchewan. His clinical expertise encompasses cardiovascular diagnostics and hematological disorders in companion animals. Research Focus: Dr. Carr's investigations center on electrocardiography interpretation, blood pressure dynamics, and platelet function assessment. His work aims to refine diagnostic approaches for cardiac and coagulation abnormalities in veterinary patients. Publication Analysis: Recent research (2016-2020) addresses critical care scenarios including xylitol toxicity management, fluid resuscitation strategies, and anesthetic monitoring in recumbent horses. His scholarship consistently emphasizes practical clinical applications with direct relevance to veterinary practice.

Gabriele CassoView profile

Professor

• Anesthesiology
• Intensive Care Medicine
• Difficult Airway Management
• +7 more

Gabriele Casso is a Full Professor at the Faculty of Biology and Medicine, University of Lausanne (UNIL), appointed in December 2023. He is affiliated with the Anesthesiology Department of CHUV and serves as Deputy Head Physician in Cardiovascular Intensive Care at Cardiocentro Ticino, Lugano. His academic and clinical work bridges anesthesiology, critical care, and emergency medicine. His educational background includes a Federal Medical Diploma (1996) and a Doctorate in Medicine (MD, 2000) from UNIL. He holds ISFM specialist titles in Anesthesia, Intensive Care, and Hospital Emergency Medicine, and has held key clinical leadership roles since 2004. Gabriele Casso's research focuses on difficult airway management , particularly the development of a high-fidelity virtual bronchoscopy simulator and AI-based 3D reconstruction of pathological airways from CT scans. He also investigates perioperative hemostasis and platelet function in cardiac anesthesia. His work integrates clinical innovation with medical education and simulation. The trends in his recent publications reflect a strong focus on airway safety, critical care outcomes, and technological innovation in anesthesia. Topics include mechanical CPR devices, lung isolation training, transfusion alternatives, and echocardiographic guidance in valve repair—spanning clinical reviews, guidelines, and case reports. Swiss Latin Airway Guidelines (2022) TTM2 Trial on Hypothermia after Cardiac Arrest (2021) 3D Echocardiography in Mitral Repair (2017) Transfusion Safety and Alternatives (2016) He has been a medical educator since 2005, serving as an instructor in Advanced Cardiac and Trauma Life Support (ACLS, ATLS). He was a Private Lecturer (Privat Dozent) at UNIL from 2018 to 2023 and has been a faculty member at the Università della Svizzera italiana since 2021. He has authored numerous peer-reviewed articles and textbook contributions in anesthesiology and critical care. He is fluent in Italian, French, English, and German. He is actively involved in research and clinical innovation at Cardiocentro Ticino and collaborates with academic institutions in Lausanne and Lugano. His leadership in simulation-based training and airway safety initiatives underscores his commitment to patient safety and medical education.

Jennifer Lyrah Bercaw-PrattView profile

Associate Professor

• Pediatric and Adolescent Gynecology
• Reproductive Endocrinology
• Disorders of Sexual Development
• +5 more

Jennifer Lyrah Bercaw-Pratt, M.D., is an Associate Professor in the Department of Obstetrics and Gynecology at Baylor College of Medicine, Houston, TX. She practices clinically at Texas Children's Hospital, focusing on pediatric and adolescent gynecology. She is board certified in Obstetrics and Gynecology and holds fellowships in the American College of Obstetricians and Gynecologists and the American Academy of Pediatrics. Education: BS, Mississippi State University (2000) MD, Louisiana State University Health Science Center (2004) Residency: Baylor College of Medicine (2008) Fellowship: Pediatric and Adolescent Gynecology, Baylor College of Medicine (2010) Her research and clinical interests center on pediatric reproductive endocrinology, disorders of sexual development, and minimally invasive surgical techniques in young patients. She has contributed to multiple clinical studies on precocious puberty, Müllerian anomalies, and adolescent reproductive health. The recent publications reflect a strong focus on diagnostic approaches in pediatric gynecology, hormonal disorders, and behavioral health aspects in adolescents. Key themes include the use of imaging for congenital anomalies, management of bleeding disorders in menstruating teens, and social trends such as pubic hair removal. Dr. Bercaw-Pratt is affiliated with the North American Society of Pediatric and Adolescent Gynecology and maintains active clinical and academic roles at Baylor and Texas Children’s Hospital. While no formal awards are listed, her consistent publication record demonstrates scholarly engagement. She collaborates extensively with colleagues such as Dr. Jennifer E. Dietrich and Dr. Ximena M. Santos on clinical research. Her work supports evidence-based care for complex gynecologic conditions in children and adolescents, with implications for both clinical practice and patient education.

• Liver Fibrosis
• Hepatology
• Stem Cell Research
• +3 more

Stefaan Verhulst is a Postdoctoral Researcher at the Flow Cytometry Core Facility within the Basic (bio-) Medical Sciences unit at Vrije Universiteit Brussel (VUB), Belgium. His work centers on liver disease mechanisms with emphasis on fibrosis, hepatic stellate cell biology, and stem cell-based modeling approaches. His research integrates advanced cellular models including iPSC-derived liver organoids and precision-cut liver slices with single-cell genomic techniques to investigate liver fibrosis progression, drug-induced injury, and cellular communication pathways. Key focus areas include biomarker discovery for liver cirrhosis, stem cell differentiation protocols, and bioinformatic analysis of disease mechanisms across multiple etiologies. With 89 research outputs showing accelerating productivity (21 publications in 2022 alone), his work demonstrates significant translational impact in hepatology. Current projects address anti-fibrotic therapies, flow cytometry infrastructure development, and educational leadership through the EUTOPIA consortium. Dr. Verhulst actively supervises students as evidenced by PhD committee memberships and 'Supervised Work (2)' documentation. His grant portfolio includes three active projects demonstrating sustained funding success in both basic and applied research domains. As director of the Flow Cytometry Core Facility, he provides critical cell analysis services to the VUB research community while advancing his own work on liver disease models. His international collaborations span multiple countries as visualized in the institutional network map.

• Molecular Biology
• Genetics
• Leukemia Research
• +4 more

Lucio Castilla is a Professor at UMass Chan Medical School, holding multiple positions across the T.H. Chan School of Medicine and Morningside Graduate School of Biomedical Sciences. His primary appointment is in the Department of Molecular, Cell and Cancer Biology, with additional affiliations in the Program in Molecular Medicine and several graduate programs including Cancer Biology and the MD/PhD Program. Dr. Castilla received his B.S. from the University of Buenos Aires in 1988 and his Ph.D. in Genetics from the University of Michigan in 1995. He completed his postdoctoral training at the National Institutes of Health from 1995 to 2000 before joining UMass Medical School as an Assistant Professor in 2000. Dr. Castilla's research focuses on understanding the molecular mechanisms of leukemia development, particularly the role of core-binding factor (CBF) in hematopoietic stem cells and leukemogenesis. His laboratory uses conditional knock-in and knock-out mouse models to study how genetic alterations in CBF subunits (RUNX1 or CBFβ) lead to acute myeloid leukemia. The lab also investigates collaborating genes that work with Cbfb-MYH11 in leukemogenesis and characterizes leukemia-initiating cells to identify potential therapeutic targets. Analysis of Dr. Castilla's recent publications reveals a strong focus on inv(16) acute myeloid leukemia, with particular attention to the CBFβ-SMMHC fusion protein. His research spans molecular mechanisms, mouse models, and translational approaches to target leukemia-initiating cells. Recent work has expanded into familial platelet disorders associated with RUNX1 mutations and the inflammatory microenvironment's role in hematologic malignancies. Dr. Castilla has received numerous prestigious awards throughout his career: Special Fellow Award from the Leukemia and Lymphoma Society (1999) AACR-Sidney Kimmel Symposium for Cancer Research Scholar Award (2002) Leukemia and Lymphoma Society Scholar (2007-2012) UMASS-Medical School Dean's Award for Outstanding Faculty Contribution to Graduate Education (2011) Fellow in Medical Sciences of the American Association for the Advancement of Science (2021) As a dedicated educator, Dr. Castilla has mentored numerous graduate students and postdoctoral fellows. His laboratory actively participates in the UMass Medical School's graduate programs, offering rotation projects focused on hematopoietic stem cell function, leukemia initiation mechanisms, and translational research approaches. The lab has secured significant research funding to support its investigations into leukemia mechanisms and targeted therapies. The Castilla Laboratory maintains an active research team including research specialists, postdoctoral associates, and graduate students. The lab has developed important mouse models for studying inv(16) AML and RUNX1-related disorders, contributing significantly to the understanding of leukemia-initiating cells and potential therapeutic approaches targeting CBFβ-SMMHC interactions.

• Multiple Myeloma
• Genomics
• Precision Medicine
• +6 more

Prof Siobhan Glavey holds the RCSI Chair and Professor of Pathology position, with dual affiliation at Royal College of Surgeons in Ireland (RCSI) and Beaumont Hospital. She serves as a Consultant Haematologist and Principal Investigator, leading clinical and translational research in multiple myeloma and precision medicine. Professor of Pathology, RCSI (2020-present) Honorary Senior Clinical Lecturer, RCSI (2019-2020) Clinician Scientist, RCSI and Beaumont Hospital (2019-present) Her research focuses on genomic profiling of multiple myeloma, particularly chromosome 1 abnormalities and SKY-92 high-risk subtypes. She investigates spatial immune cell relationships in bone marrow using AI algorithms, and develops novel therapeutic strategies including 5-azacytidine/venetoclax combinations and adoptive immunotherapy approaches. Recent publications highlight her work on: Genomic instability in high-risk myeloma AI-driven spatial pathology analysis Thromboprophylaxis challenges in myeloma Bispecific antibody safety/efficacy Myeloma microenvironment interactions She has secured competitive funding from: Health Research Board (HRB) Irish Cancer Society Breakthrough Cancer Research Beaumont Hospital Foundation Pfizer Industry Grants

Kristin ScheibleView profile

Associate Professor

• Neonatology
• Immunology
• T cell development
• +7 more

Kristin Scheible, M.D. is an Associate Professor in the Department of Pediatrics (Neonatology) and Department of Microbiology and Immunology at the University of Rochester School of Medicine and Dentistry. She serves as a neonatologist at UR Medicine providing clinical care to newborns while leading an active research program focused on neonatal immunology and microbiome development. As part of the extracorporeal membrane oxygenation (ECMO) team, Dr. Scheible has a special interest in caring for babies with persistent pulmonary hypertension. Dr. Scheible completed her medical education at the University of Rochester School of Medicine/Dentistry in 2004, followed by a Pediatrics residency (2004-2007) and Neonatology fellowship (2007-2010), all at the University of Rochester Medical Center. Her educational background includes undergraduate honors in Anthropology and German studies. Dr. Scheible's research focuses on understanding how premature birth disrupts normal T cell development and the clinical consequences of abnormal immune development during infancy. Her lab employs high-parameter flow cytometric and high-throughput sequencing approaches to investigate T cell receptor, cytokine signaling, and functional differences in developing immune cells. She has discovered that premature infants exist in a clinical paradox where their T cells are able to activate but not protect against infections. A major finding from her lab demonstrated that the co-development of the gut microbiome, respiratory system, and immune system directly impacts infant respiratory health. Her research spans molecular mechanisms of immune development to population-level studies examining environmental exposures. Dr. Scheible has received numerous awards including the American Thoracic Society Abstract Award (2017), University of Rochester Bronze Star (2014), multiple Patient-and Family-Centered Care Awards (2012-2013), and the University of Rochester Strong Star (2011-2016). She also received the prestigious Ruth L. Kirschstein National Research Service Award (2008-2011) and has been recognized for excellence throughout her academic career dating back to undergraduate studies. As Principal Investigator of the Scheible Lab, she mentors several graduate students including Darline Castro-Melendez (Ph.D. Candidate studying PFAS exposure and neonatal immunity) and Janiret Narvaez-Miranda (Ph.D. Candidate investigating infant gut microbiome and vaccine responses). Her lab participates in major research consortia including the Prematurity and Respiratory Outcomes Program (PROP) and the Environmental Influences on Child Health Outcomes (ECHO) program. Dr. Scheible collaborates extensively with researchers across disciplines including Neonatology, Obstetrics, Infectious Diseases, Microbiology, Immunology, Genetics, Biostatistics, and Computational Biology. The Scheible Lab operates within the University of Rochester Medical Center's Department of Pediatrics, conducting translational research that bridges basic science discoveries with clinical applications for neonatal care. Current projects include gene regulatory profiling optimized for minimal sample input, investigating neurobiological consequences of microbiome trajectories, examining roles of CD8+ T cell microRNAs, and studying alternate mechanisms of immune protection against novel infections during infancy.

• Sports Medicine
• Preventive Physical Activity
• Human Anatomy
• +5 more

Giuliana Gobbi is a Professor at the Department of Medicine and Surgery, University of Parma. She specializes in Sports Medicine and Preventive Physical Activity, with a focus on motor activity adaptations for different age groups and populations with special needs. Her academic roles include teaching courses like 'Theory and Methods of Preventive and Adapted Physical Activities' and 'Human Anatomy' across undergraduate and graduate programs in Medicine, Sports Sciences, and Dental Medicine. Her research spans biomechanics, postural stability in neurological disorders, and the impact of physical activity on health. Notable studies include analyzing wheelchair Paralympic table tennis techniques and investigating the role of protein kinase C epsilon in muscle differentiation. She has contributed to health promotion projects like the 'Activate your Wait' initiative to encourage physical activity in daily life. Her work integrates clinical, anatomical, and molecular approaches, with over 50 peer-reviewed publications. She collaborates on interdisciplinary projects linking sports science with cardiology and neurology, emphasizing practical applications of research in clinical and community settings.

• Neuro-Ophthalmology
• Brain Injury Recovery
• Visual Processing
• +5 more

Jeffrey Alan Gluckstein, MD, is an Assistant Professor of Clinical Ophthalmology at the Keck School of Medicine of USC. His clinical expertise focuses on neuro-ophthalmology, addressing conditions affecting the optic nerve, visual pathways, and eye-brain connectivity. He leads research into vision recovery post-brain injury, emphasizing translational strategies to improve outcomes in patients with neurologically damaged visual systems. Research Interests: Dr. Gluckstein’s work bridges clinical practice and innovation, including telemedicine applications for eye care accessibility and AI-driven diagnostic tools for glaucoma detection. His studies also explore socioeconomic barriers in neuro-ophthalmology and diversity in academic medicine. Awards: Gold Humanism Honor Society (2015), Alpha Omega Alpha (2015), and Excellence in Neurology Award (2016). Clinical Practice: Sees patients at locations in Arcadia, Los Angeles, and Glendale, with proficiency in Spanish and English. Publications: His recent work highlights AI’s role in glaucoma screening (2025), telemedicine during the pandemic (2024), and case studies on SARS-CoV-2 optic neuropathy (2023). He also advocates for reducing disparities in medical specialty access. Grants & Collaborations: Involved in global health initiatives like the Tanzania-based MAMBO trial (2021) assessing post-stroke treatments.

• Cell Biology
• Stem Cell Research
• Hematopoiesis
• +3 more

Elisa Bianchi is Associate Professor of Applied Cell Biology at Unimore's Centre for Regenerative Medicine. Her research deciphers molecular mechanisms in hematopoiesis, with emphasis on myeloproliferative neoplasms (MPNs), stem cell differentiation, and oxidative stress pathways. She has identified key roles for miRNAs, TGF-β signaling, and osteopontin in bone marrow fibrosis. Recent work explores chromosomal abnormalities in JAK2-mutant MPNs and regenerative applications for liver disease. Dr. Bianchi teaches cellular biology and laboratory techniques for biotechnology students. She coordinates research on genomic instability in hematologic malignancies.